Brother Enterprises (SZ:002562) Xin Lang Cai Jing·2025-09-22 13:34Group 1 - The company conducted an online investor meeting on September 22, 2025, with nine investment institutions including Shanghai Haineng Investment and Jiangsu Gaotou Venture Capital [1] - The company has successfully entered the PEEK field by optimizing the process of phenol production, which is a core raw material for PEEK, previously supplied mainly by foreign companies [1] - The price of Vitamin B1 has increased compared to the same period last year, while other vitamin products have remained stable or slightly decreased [1] Group 2 - The company has expanded its market for iodine contrast agents, primarily selling to India, Turkey, and Russia, and has established a broad cooperation with Qidu Pharmaceutical to develop the domestic market [1] - The investor meeting did not involve any undisclosed significant information [1]